IMD (Fujian) Pharmaceutical Co., Ltd,located in No.5 Quanling Road ,WuJiatang Industrial Park, Shaowu City, Nanping, Fujian Province, China,was founded in December ,2017. It is a production-oriented company committed to the research and development, production and sales of imidazole derivatives.MD has built an annual output of 8000 tons of imidazole lithium ion electrolyte project. With a total area of 35730.6 m2 and a total construction area of about 13444 m2 , it has 3 class A workshops, 2 Class C warehouses, 1 Class A warehouse, 3 tank areas and a 150 tons/day sewage treatment facility.
IMD currently has a production and R&D team engaged in the imidazole derivative industry for over 20 years. There are 112 production and R&D personnel, and a group of energetic and talented high-quality management personnel have been introduced.At the same time, a new product R&D center was established, and a batch of high-tech testing equipment such as GC, HPLC, digital melting point analyzer, and trace moisture analyzer were purchased. Advanced automation equipment was used for large-scale production, which made a qualitative leap in the product quality and provided reliable assurance for product quality.
IMD has currently passed the ISO9001 system certification and implemented dual system management in accordance with both the ISO9001 and GMP certification systems. At the same time, the company strictly controls the access of raw materials, control of semi-finished products, and outbound inspection of finished products according to the company's prescribed procedures. All products produced and sold by the company can be tracked and traced.